ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services

Recruiting now · Not applicable

Conditions studied: HIV, Cervical Cancer

In brief

While there has been a significant increase in the uptake of antiretroviral therapy among women living with HIV (WLHIV) in many low- and-middle income countries (LMICs), the coverage of cervical cancer screening and treatment (CCST) among WLHIV remains low. This study aims to leverage the available infrastructure for HIV care and treatment programs in Nigeria to integrate cervical cancer screening and treatment and conduct a cluster randomized, hybrid type III trial design to assess the comparative effectiveness of a Core set of implementation strategies versus a Core+ (enhanced) set of implementation strategies to implement cervical cancer screening, onsite treatment, referral and referral completion, treatment, and retention in care among WLHIV. The overarching goal is to improve the health and life expectancy of WLHIV with co-occurring cervical cancer.

Key facts

Study ID

NCT06128304

Run by

University of California, San Diego

People needed

2436

Starts

2023-11-13

Expected to finish

2027-08-31

Last updated by the study team

2026-02-10

Who can join

Age: 25 and older, up to 64. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women living with HIV

Where it is running

• UC San Diego — La Jolla, California, United States (enrolling)
• University of Nigeria, Nsukka — Enugu, Enugu State, Nigeria (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.